GSK Philippines recently announced that announced on Tuesday that the Philippine Food and Drug Administration (FDA) has approved its Meningococcal Group B Vaccine (recombinant, adsorbed), for the ...
approved on October 15 the Meningococcal Group B Vaccine of GlaxoSmithKline (GSK) Philippines, a global biopharma company. The vaccine is for the prevention of meningococcal disease caused by the ...
GlaxoSmithKline ( (GSK)) has realeased its Q3 earnings. Here is a breakdown of the information GlaxoSmithKline presented to its investors. GlaxoSmithKline (GSK) is a global biopharmaceutical ...
GSK has shifted towards a global marketing model influenced by a Netflix-style approach that aims to match content to the person receiving it. Richard Staines heard about this new strategy at the ...
Whether you’re visiting a bustling city or chilling out on a beach, prepare for your trip to the Philippines with this eco-friendly guide. The steep karst cliffs of El Nido tower over white-sand ...
Moderna to defend against GSK's claims, spokesperson says GSK seeks unspecified monetary damages from Moderna A spokesperson for Massachusetts-based Moderna said the company was aware of the ...
GSK’s NgG shot is based on generalised modules ... Germany, Spain, Brazil, the Philippines, and South Africa, with a readout expected in 2025. Meanwhile, some research has found that vaccines ...
View upcoming earnings forecasts and in-depth analysis of company forecasts.
The number of dead and missing in massive flooding and landslides wrought by Tropical Storm Trami in the Philippines has reached nearly 130 and the president said Saturday that many areas ...
Also Read: Just After Pfizer’s RSV Vaccine Approval For Younger Adults, GSK Layouts Encouraging Preliminary Data Showing Potential For Use In Larger Population Specialty Medicine sales increased ...
(Reuters) -British drugmaker GlaxoSmithKline sued Moderna in U.S. federal court in Delaware on Tuesday, accusing it of violating GSK patent rights in messenger RNA technology with its blockbuster ...